INCHEON, South Korea I February 18, 2025 I Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback